+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rigel Pharmaceuticals Inc - logo

Rigel Pharmaceuticals is a clinical-stage biotechnology company that focuses on the therapeutic areas of immunology, oncology and immuno-oncology. Rigel’s current clinical programs include clinical trials of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of a variety of diseases. It has been in trials for rheumatoid arthritis, autoimmune thrombocytopenia, lymphoma and others. In addition, Rigel also has two oncology product candidates in development. Founded in 1996, Rigel is headquartered in San Francisco, California.

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 318 Pages
  • Global
From
Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 116 Pages
  • Global
From
Thrombocytopenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 602 Pages
  • Global
From
Multiple Sclerosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1114 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • July 2020
  • 261 Pages
  • Global
From
Glomerulonephritis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Glomerulonephritis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 241 Pages
  • Global
From
Competitor Landscape: Spondyloarthritis - Product Thumbnail Image

Competitor Landscape: Spondyloarthritis

  • Report
  • November 2018
  • 64 Pages
  • Global
From
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021 - Product Thumbnail Image

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Rigel Pharmaceuticals Inc (RIGL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Rigel Pharmaceuticals Inc (RIGL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Clinical Trial Report Week 29th October - 1st November 2019 - Product Thumbnail Image

Clinical Trial Report Week 29th October - 1st November 2019

  • Report
  • February 2020
  • 5 Pages
  • Global
From
Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Comprehensive Report on Rigel Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Rigel Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 43 Pages
From
Rigel Pharmaceuticals Inc (RIGL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Rigel Pharmaceuticals Inc (RIGL) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2023
  • 52 Pages
From
Loading Indicator